VAP

David Palmer to Join Global Blockchain Show 2024 as a Speaker

Retrieved on: 
Wednesday, February 14, 2024

Dubai, United Arab Emirates--(Newsfile Corp. - February 14, 2024) - Global Blockchain Show will have David Palmer, Chief Product Officer, Co-founder, Vodafone's Digital Asset Broker (DAB) Platform, Vadafone, to speak as a panelist at Grand Hyatt Dubai from 16-17 April 2024.

Key Points: 
  • Dubai, United Arab Emirates--(Newsfile Corp. - February 14, 2024) - Global Blockchain Show will have David Palmer, Chief Product Officer, Co-founder, Vodafone's Digital Asset Broker (DAB) Platform, Vadafone, to speak as a panelist at Grand Hyatt Dubai from 16-17 April 2024.
  • One of the largest blockchain gatherings is all set to take place in 2024 in Dubai with the Global Blockchain Show curated by the blockchain-based organization, VAP Group.
  • The event will have world-renowned blockchain experts from various corners of the world who will unite with the agenda to promote the blockchain industry through networking, blockchain sessions, and learning.
  • David Palmer is one of the leaders in the blockchain space for Vodafone Business, a recognized Blockchain thought leader, and an expert on digital technologies, new business models, DeFi, digital identity, AI, the Metaverse, and IoT.

Global AI Show 2024 Roaring Among Other Events in Dubai

Retrieved on: 
Monday, February 5, 2024

DUBAI, Feb 5, 2024 - (ACN Newswire) - As more speakers and attendees sign up for the grand Global AI Show 2024, the much-awaited event is waiting to explode its potential in April at Grand Hyatt Dubai.

Key Points: 
  • DUBAI, Feb 5, 2024 - (ACN Newswire) - As more speakers and attendees sign up for the grand Global AI Show 2024, the much-awaited event is waiting to explode its potential in April at Grand Hyatt Dubai.
  • Global AI Show 2024 is scheduled to be held at the luxurious Grand Hyatt Dubai from 16 to 17 April 2024, offering an exceptional opportunity to share ideas, uncover the potential of AI, and network in the ever-evolving AI sector.
  • VAP Group has also chosen an exquisite location for the after-party event on the popular White Beach Dubai with a breathtaking view and a chic outdoor setting.
  • With the expertise of the GAIS speakers, participants can gather valuable and unique knowledge and build perspective about the technology, ensuring everyone has useful experience from the Global AI Show.

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 January 2024

Retrieved on: 
Sunday, February 4, 2024

Three new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended three medicines for approval at its January 2024 meeting.The committee recommended…, Positive recommendations on new medicines, Exblifep International non-proprietary name (INN)cefepime / enmetazobactam Marketing-authorisation applicantAdvanz Pharma LimitedTherapeutic indicationTreatment of: 1)…, Ryzneuta INNefbemalenograstim alfaMarketing-authorisation applicantEvive Biotechnology Ireland LimitedTherapeutic indicationReduction in the duration of neutropenia and…, Positive recommendations on new generic medicines, Niapelf INNpaliperidoneMarketing-authorisation applicantNeuraxpharm Pharmaceuticals S.L.Therapeutic indicationTreatment of schizophreniaMore informationNiapelf: Pending…, Negative recommendations on new medicines, Nezglyal INNleriglitazoneMarketing-authorisation applicantMinoryx Therapeutics S.L.Therapeutic indicationTreatment of cerebral progression and myelopathy in male…, Syfovre INNpegcetacoplanMarketing-authorisation applicantApellis Netherlands B.V.Therapeutic indicationTreatment of geographic atrophy (GA) secondary to age-related…, Positive recommendations on extensions of indications, Abecma INNidecabtagene vicleucel Marketing-authorisation holderBristol-Myers Squibb Pharma EEIGMore informationAbecma: Pending EC decision, Prevenar 20 (previously Apexxnar) Common namepneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)Marketing-authorisation holderPfizer Europe MA EEIGMore…, Aspaveli INNpegcetacoplanMarketing-authorisation holderSwedish Orphan Biovitrum AB (publ)More informationAspaveli: Pending EC decision, Retsevmo INNselpercatinibMarketing-authorisation holderEli Lilly Nederland B.V.More informationRetsevmo: Pending EC decision, Outcome of re-examination of recommendation on non-renewal of Conditional Marketing Authorisation, Translarna INNataluren Marketing-authorisation holderPTC Therapeutics International LimitedNewsEMA confirms recommendation for non-renewal of authorisation of Duchenne…, Outcome of referral, Pseudoephedrine Marketing-authorisation holderVarious companiesMore informationPseudoephedrine-containing medicinal products, Re-examination of conclusion of referral, Synapse Labs Pvt.

Key Points: 
  • Three new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended three medicines for approval at its January 2024 meeting.The committee recommended…, Positive recommendations on new medicines, Exblifep International non-proprietary name (INN)cefepime / enmetazobactam Marketing-authorisation applicantAdvanz Pharma LimitedTherapeutic indicationTreatment of: 1)…, Ryzneuta INNefbemalenograstim alfaMarketing-authorisation applicantEvive Biotechnology Ireland LimitedTherapeutic indicationReduction in the duration of neutropenia and…, Positive recommendations on new generic medicines, Niapelf INNpaliperidoneMarketing-authorisation applicantNeuraxpharm Pharmaceuticals S.L.Therapeutic indicationTreatment of schizophreniaMore informationNiapelf: Pending…, Negative recommendations on new medicines, Nezglyal INNleriglitazoneMarketing-authorisation applicantMinoryx Therapeutics S.L.Therapeutic indicationTreatment of cerebral progression and myelopathy in male…, Syfovre INNpegcetacoplanMarketing-authorisation applicantApellis Netherlands B.V.Therapeutic indicationTreatment of geographic atrophy (GA) secondary to age-related…, Positive recommendations on extensions of indications, Abecma INNidecabtagene vicleucel Marketing-authorisation holderBristol-Myers Squibb Pharma EEIGMore informationAbecma: Pending EC decision, Prevenar 20 (previously Apexxnar) Common namepneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)Marketing-authorisation holderPfizer Europe MA EEIGMore…, Aspaveli INNpegcetacoplanMarketing-authorisation holderSwedish Orphan Biovitrum AB (publ)More informationAspaveli: Pending EC decision, Retsevmo INNselpercatinibMarketing-authorisation holderEli Lilly Nederland B.V.More informationRetsevmo: Pending EC decision, Outcome of re-examination of recommendation on non-renewal of Conditional Marketing Authorisation, Translarna INNataluren Marketing-authorisation holderPTC Therapeutics International LimitedNewsEMA confirms recommendation for non-renewal of authorisation of Duchenne…, Outcome of referral, Pseudoephedrine Marketing-authorisation holderVarious companiesMore informationPseudoephedrine-containing medicinal products, Re-examination of conclusion of referral, Synapse Labs Pvt.
  • Ltd. Marketing-authorisation holderVarious companiesMore informationSynapse

Dubai 2024 Welcomes the Pinnacle of Blockchain Innovation: The Global Blockchain Show

Retrieved on: 
Tuesday, January 30, 2024

DUBAI, Jan 30, 2024 - (ACN Newswire) - Join the Global Blockchain Show 2024 in Dubai - an innovation hub showcasing pioneering blockchain technology and visionary experts, April 16-17.

Key Points: 
  • DUBAI, Jan 30, 2024 - (ACN Newswire) - Join the Global Blockchain Show 2024 in Dubai - an innovation hub showcasing pioneering blockchain technology and visionary experts, April 16-17.
  • The Global Blockchain Show 2024 is set to take place in the magnificent city of Dubai, which is popular for its modern architecture and innovative approach.
  • The visionaries in VAP Group are responsible for organizing Global Blockchain Show 2024, a highly anticipated global event.
  • The CEO of VAP Group, Vishal Parmar, has a bigger picture for the Global Blockchain Show 2024 than just discussing what is to come.

T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients

Retrieved on: 
Thursday, January 18, 2024

LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced participation in the NIH-funded Antibacterial Resistance Leadership Group (ARLG) pilot study for pneumonia patients.

Key Points: 
  • LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced participation in the NIH-funded Antibacterial Resistance Leadership Group (ARLG) pilot study for pneumonia patients.
  • The Pneumonia Direct Pilot study is a prospective, observational, diagnostic, feasibility study to determine the accuracy of multiple pathogen- and host-directed tests for the diagnosis of ventilator-associated pneumonia (VAP).
  • “I am elated that the innovative research leaders of Antibacterial Resistance Leadership Group are collaborating with T2 Biosystems to evaluate direct-from-blood diagnostic technology for the management of patients with pneumonia.
  • The extremely low level of detection by T2 Biosystems’ technology (“T2MR”) in whole blood (1 – 11 CFU/mL) has been effective in detecting secondary infections.

Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results

Retrieved on: 
Monday, January 22, 2024

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today reported its financial results for the first fiscal quarter ended November 30, 2023.

Key Points: 
  • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today reported its financial results for the first fiscal quarter ended November 30, 2023.
  • Revenues were $3,891,218, representing an increase of $471,938, or 14%, from $3,419,280 for the same period in 2022.
  • Revenue from our healthcare services increased by 1.2% when comparing the revenue for the same period in 2022.
  • Upon closing of the acquisition of the Ophir Collection, the Company intends to monetize the Ophir Collection.

Global Blockchain Show Dubai: A Grand Blockchain Experts Gathering in April 2024

Retrieved on: 
Monday, January 15, 2024

Dubai, United Arab Emirates--(Newsfile Corp. - January 15, 2024) - VAP Group to curate one of the biggest gatherings of blockchain experts at the Global Blockchain Show.

Key Points: 
  • Dubai, United Arab Emirates--(Newsfile Corp. - January 15, 2024) - VAP Group to curate one of the biggest gatherings of blockchain experts at the Global Blockchain Show.
  • To view an enhanced version of this graphic, please visit:
    The vibrant city, Dubai, is all set to celebrate Dubai Blockchain Week in April 2024 by hosting multiple grand events of the industry.
  • Scheduled for 16-17 April 2024, the Global Blockchain Show Dubai will be held at the luxurious Grand Hyatt Dubai.
  • The attendee list for the Global Blockchain Show comprises primarily startups and scale-ups (46%) looking to find investment and marketing prospects.

Ali Abdullah Al Sadadi to Speak at Dubai's Most Impactful Tech Event - Global AI Show 2024

Retrieved on: 
Monday, January 15, 2024

Dubai, United Arab Emirates--(Newsfile Corp. - January 15, 2024) - Among the 300 speakers, Al Abdullah Al Sadadi joins the Global AI Show to share his insights and build connections within the industry.

Key Points: 
  • Dubai, United Arab Emirates--(Newsfile Corp. - January 15, 2024) - Among the 300 speakers, Al Abdullah Al Sadadi joins the Global AI Show to share his insights and build connections within the industry.
  • Global AI Show by VAP Group is set to have a large gathering of over 7000 attendees, 300 speakers, and 3000 companies, who will come together at Grand Hyatt Dubai from 16–17 April 2024.
  • The event will connect global AI experts, startups, and innovators with pre-qualified C-level executives, including CEOs, government authorities, and other professionals in the AI industry.
  • This opportunity brings a unique and enriching dimension to the discourse, aiming to ensure a rewarding experience for all attendees.

Dubai to host global AI leaders as the UAE ramps up its National Vision for Artificial Intelligence

Retrieved on: 
Monday, January 15, 2024

DUBAI, Jan 15, 2024 - (ACN Newswire) - Grand Hyatt Dubai is all set to host the highly anticipated Global AI Show on 16-17 April, 2024.

Key Points: 
  • DUBAI, Jan 15, 2024 - (ACN Newswire) - Grand Hyatt Dubai is all set to host the highly anticipated Global AI Show on 16-17 April, 2024.
  • Event managed by VAP Group - a premier blockchain and AI consulting brand, is set to gather prominent figures from the Middle East's AI, ML and RPA arenas.
  • Recognizing this potential and the existing gap, Global AI Show - Dubai aims to bridge these industry divides.
  • The event will be a deep dive into AI, bringing together new ideas, knowledge, and growth in this changing tech field.

Global Blockchain Show, Dubai, to Gather Blockchain and Web3 Experts, Provide Networking Opportunities

Retrieved on: 
Thursday, January 11, 2024

VAP Group, a leader in Web3 & Crypto Innovation, to host the biggest blockchain event in the heart of Dubai at Grand Hyatt Dubai from 16-17 April 2024

Key Points: 
  • Among the attendees and speakers, the Global Blockchain Show Dubai will have C-level executives, managers, consultants, corporates, investors, and even governments who will stand to gain valuable insights from this blockchain event and participate in networking opportunities to build collaborations and partnerships.
  • VAP Group has been leading the AI and Blockchain consulting domain for more than a decade now and is committed to promoting blockchain innovation among young entrepreneurs and crypto enthusiasts.
  • Vishal Parmar, the CEO of VAP Group, says, "At the Global Blockchain Show in Dubai, we're shaping the future of Blockchain and Web3.
  • There will be engaging networking opportunities and panel discussions on Blockchain advancements and production cases.